BIOMAT Database Logo BIOMAT Database Logo

[Respiratory depression due to pentazocine, halothane, N2O anesthesia and its reversal by naloxone]. 1982

Y Watanabe, and K Yasuda, and E Ikezono

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D009458 Neuroleptanalgesia A form of analgesia accompanied by general quiescence and psychic indifference to environmental stimuli, without loss of consciousness, and produced by the combined administration of a major tranquilizer (neuroleptic) and a narcotic. Neuroleptoanalgesia
D009609 Nitrous Oxide Nitrogen oxide (N2O). A colorless, odorless gas that is used as an anesthetic and analgesic. High concentrations cause a narcotic effect and may replace oxygen, causing death by asphyxia. It is also used as a food aerosol in the preparation of whipping cream. Laughing Gas,Nitrogen Protoxide,Gas, Laughing,Oxide, Nitrous
D010423 Pentazocine The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97) Fortral,Lexir,Pentazocine Hydrochloride,Pentazocine Lactate,Talwin,Hydrochloride, Pentazocine,Lactate, Pentazocine
D011184 Postoperative Period The period following a surgical operation. Period, Postoperative,Periods, Postoperative,Postoperative Periods
D012119 Respiration The act of breathing with the LUNGS, consisting of INHALATION, or the taking into the lungs of the ambient air, and of EXHALATION, or the expelling of the modified air which contains more CARBON DIOXIDE than the air taken in (Blakiston's Gould Medical Dictionary, 4th ed.). This does not include tissue respiration ( Breathing
D006221 Halothane A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178) 1,1,1-Trifluoro-2-Chloro-2-Bromoethane,Fluothane,Ftorotan,Narcotan
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Y Watanabe, and K Yasuda, and E Ikezono
Naloxone reversal of pentazocine-induced respiratory depression.
June 1968, JAMA,
Y Watanabe, and K Yasuda, and E Ikezono
Proceedings: Effects of nalorphine and naloxone on respiratory depression of rabbits due to pentazocine. 4.
January 1974, Japanese journal of pharmacology,
Y Watanabe, and K Yasuda, and E Ikezono
The reversal of pentazocine-induced respiratory depression.
April 1970, Anaesthesia,
Y Watanabe, and K Yasuda, and E Ikezono
[The effects of naloxone reversal on enflurane-N2O-O2 anesthesia].
October 1984, Masui. The Japanese journal of anesthesiology,
Y Watanabe, and K Yasuda, and E Ikezono
Naloxone reversal of buprenorphine-induced respiratory depression.
July 2006, Anesthesiology,
Y Watanabe, and K Yasuda, and E Ikezono
Naloxone reversal of buprenorphine-induced respiratory depression.
January 1989, Clinical pharmacology and therapeutics,
Y Watanabe, and K Yasuda, and E Ikezono
[Reversal of high-dose fentanyl anesthesia by naloxone: analysis of factors attenuating respiratory and hemodynamic responses to naloxone].
March 1991, Masui. The Japanese journal of anesthesiology,
Y Watanabe, and K Yasuda, and E Ikezono
Potency of metocurine during halothane-N2O and N2O-narcotic anesthesia.
January 1978, Anesthesia and analgesia,
Y Watanabe, and K Yasuda, and E Ikezono
Neutrophil chemotaxis during halothane and halothane-N2O anesthesia in man.
January 1977, Anesthesia and analgesia,
Y Watanabe, and K Yasuda, and E Ikezono
Respiratory depression following diazepam: reversal with high-dose naloxone.
October 1980, Anesthesiology,
Copied contents to your clipboard!